Johnson Investment Counsel’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$457K Hold
2,445
– – ﹤0.01% 637
2026
Q1
$461K Hold
2,445
– – ﹤0.01% 601
2025
Q4
$486K Buy
2,445
+112
+5% +$22.6K ﹤0.01% 555
2025
Q3
$474K Buy
2,333
+18
+0.8% +$3.19K ﹤0.01% 597
2025
Q2
$407K Hold
2,315
– – ﹤0.01% 598
2025
Q1
$311K Hold
2,315
– – ﹤0.01% 631
2024
Q4
$292K Hold
2,315
– – ﹤0.01% 658
2024
Q3
$385K Hold
2,315
– – ﹤0.01% 565
2024
Q2
$308K Hold
2,315
– – ﹤0.01% 591
2024
Q1
$243K Buy
+2,315
New +$208K ﹤0.01% 657

Other funds holding THC

Johnson Investment Counsel's THC Position: Q2 2026 in Review

Johnson Investment Counsel held its Tenet Healthcare (THC) position steady in Q2 2026 at 2,445 shares worth $457K. The position accounts for ﹤0.01% of the portfolio, ranked #637.

Johnson Investment Counsel first reported a position in THC in Q1 2024 and has held it in 10 quarters since. The position peaked at $486K in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Johnson Investment Counsel held 2,445 shares of Tenet Healthcare worth $457K as of Q2 2026.
  • Johnson Investment Counsel left its Tenet Healthcare share count unchanged in Q2 2026.
  • Tenet Healthcare made up ﹤0.01% of Johnson Investment Counsel's portfolio in Q2 2026, its #637 holding.
  • Johnson Investment Counsel first reported a position in Tenet Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Johnson Investment Counsel's Tenet Healthcare position peaked at $486K in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Johnson Investment Counsel's 13F filing for Q2 2026, filed 23 Jul 2026.